Among all leukemia subtypes, CD33 exhibited a robust enrichment in AML and CML (chronic myelogenous leukemia), while IL1B correlated best with pediatric ALL and considerably with AML (Figure 7D). This evidence concerns the gene CD33 and chronic myelogenous leukemia, BCR-ABL1 positive.